nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—HTR2B—Sorafenib—liver cancer	0.268	0.413	CbGbCtD
Bromocriptine—HTR2C—Sorafenib—liver cancer	0.174	0.269	CbGbCtD
Bromocriptine—CYP1A2—Sorafenib—liver cancer	0.0634	0.0979	CbGbCtD
Bromocriptine—ABCB1—Sorafenib—liver cancer	0.0554	0.0856	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—liver cancer	0.0336	0.0519	CbGbCtD
Bromocriptine—CYP3A4—Sorafenib—liver cancer	0.0332	0.0513	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—liver cancer	0.0202	0.0311	CbGbCtD
Bromocriptine—Pleural effusion—Sorafenib—liver cancer	0.00417	0.023	CcSEcCtD
Bromocriptine—Rhinorrhoea—Sorafenib—liver cancer	0.00394	0.0218	CcSEcCtD
Bromocriptine—Neurotoxicity—Epirubicin—liver cancer	0.00304	0.0168	CcSEcCtD
Bromocriptine—Pericardial effusion—Epirubicin—liver cancer	0.00288	0.0159	CcSEcCtD
Bromocriptine—Laboratory test abnormal—Epirubicin—liver cancer	0.00282	0.0156	CcSEcCtD
Bromocriptine—Neurotoxicity—Doxorubicin—liver cancer	0.00282	0.0156	CcSEcCtD
Bromocriptine—Pericarditis—Epirubicin—liver cancer	0.00273	0.0151	CcSEcCtD
Bromocriptine—Pericardial effusion—Doxorubicin—liver cancer	0.00266	0.0147	CcSEcCtD
Bromocriptine—Laboratory test abnormal—Doxorubicin—liver cancer	0.00261	0.0144	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Sorafenib—liver cancer	0.00256	0.0141	CcSEcCtD
Bromocriptine—Pericarditis—Doxorubicin—liver cancer	0.00252	0.014	CcSEcCtD
Bromocriptine—Abdominal pain upper—Sorafenib—liver cancer	0.00212	0.0117	CcSEcCtD
Bromocriptine—Nasopharyngitis—Sorafenib—liver cancer	0.00207	0.0115	CcSEcCtD
Bromocriptine—Dysphagia—Sorafenib—liver cancer	0.002	0.0111	CcSEcCtD
Bromocriptine—Abdominal discomfort—Sorafenib—liver cancer	0.00192	0.0106	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Sorafenib—liver cancer	0.00176	0.00973	CcSEcCtD
Bromocriptine—Myocardial infarction—Sorafenib—liver cancer	0.00175	0.00968	CcSEcCtD
Bromocriptine—Burning sensation—Epirubicin—liver cancer	0.0017	0.00939	CcSEcCtD
Bromocriptine—Dermatitis atopic—Epirubicin—liver cancer	0.00159	0.00881	CcSEcCtD
Bromocriptine—Connective tissue disorder—Sorafenib—liver cancer	0.00158	0.00871	CcSEcCtD
Bromocriptine—Burning sensation—Doxorubicin—liver cancer	0.00157	0.00869	CcSEcCtD
Bromocriptine—Pleural effusion—Epirubicin—liver cancer	0.00154	0.00852	CcSEcCtD
Bromocriptine—Amblyopia—Epirubicin—liver cancer	0.00153	0.00845	CcSEcCtD
Bromocriptine—Tinnitus—Sorafenib—liver cancer	0.00149	0.00826	CcSEcCtD
Bromocriptine—Cardiac disorder—Sorafenib—liver cancer	0.00149	0.00822	CcSEcCtD
Bromocriptine—Dermatitis atopic—Doxorubicin—liver cancer	0.00148	0.00815	CcSEcCtD
Bromocriptine—Angiopathy—Sorafenib—liver cancer	0.00145	0.00804	CcSEcCtD
Bromocriptine—Mediastinal disorder—Sorafenib—liver cancer	0.00145	0.00799	CcSEcCtD
Bromocriptine—Arrhythmia—Sorafenib—liver cancer	0.00143	0.00792	CcSEcCtD
Bromocriptine—Pleural effusion—Doxorubicin—liver cancer	0.00143	0.00788	CcSEcCtD
Bromocriptine—Alopecia—Sorafenib—liver cancer	0.00142	0.00783	CcSEcCtD
Bromocriptine—Amblyopia—Doxorubicin—liver cancer	0.00141	0.00781	CcSEcCtD
Bromocriptine—Mental disorder—Sorafenib—liver cancer	0.0014	0.00776	CcSEcCtD
Bromocriptine—Delirium—Epirubicin—liver cancer	0.00137	0.00758	CcSEcCtD
Bromocriptine—Dysgeusia—Sorafenib—liver cancer	0.00137	0.00755	CcSEcCtD
Bromocriptine—Muscle spasms—Sorafenib—liver cancer	0.00134	0.00742	CcSEcCtD
Bromocriptine—Delirium—Doxorubicin—liver cancer	0.00127	0.00702	CcSEcCtD
Bromocriptine—Dyskinesia—Epirubicin—liver cancer	0.00126	0.00694	CcSEcCtD
Bromocriptine—Syncope—Sorafenib—liver cancer	0.00125	0.00692	CcSEcCtD
Bromocriptine—Loss of consciousness—Sorafenib—liver cancer	0.00123	0.00678	CcSEcCtD
Bromocriptine—Hypertension—Sorafenib—liver cancer	0.00121	0.00666	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00118	0.00652	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Epirubicin—liver cancer	0.00118	0.00652	CcSEcCtD
Bromocriptine—Dry mouth—Sorafenib—liver cancer	0.00116	0.00642	CcSEcCtD
Bromocriptine—Dyskinesia—Doxorubicin—liver cancer	0.00116	0.00642	CcSEcCtD
Bromocriptine—Infection—Sorafenib—liver cancer	0.00113	0.00625	CcSEcCtD
Bromocriptine—Shock—Sorafenib—liver cancer	0.00112	0.00619	CcSEcCtD
Bromocriptine—Nervous system disorder—Sorafenib—liver cancer	0.00112	0.00617	CcSEcCtD
Bromocriptine—Skin disorder—Sorafenib—liver cancer	0.00111	0.00612	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Doxorubicin—liver cancer	0.00109	0.00603	CcSEcCtD
Bromocriptine—Anorexia—Sorafenib—liver cancer	0.00109	0.006	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Epirubicin—liver cancer	0.00108	0.00599	CcSEcCtD
Bromocriptine—Dyspnoea—Sorafenib—liver cancer	0.00102	0.00561	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Doxorubicin—liver cancer	0.001	0.00554	CcSEcCtD
Bromocriptine—Dyspepsia—Sorafenib—liver cancer	0.001	0.00554	CcSEcCtD
Bromocriptine—Decreased appetite—Sorafenib—liver cancer	0.00099	0.00547	CcSEcCtD
Bromocriptine—Diabetes mellitus—Epirubicin—liver cancer	0.000985	0.00544	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000983	0.00544	CcSEcCtD
Bromocriptine—Fatigue—Sorafenib—liver cancer	0.000982	0.00543	CcSEcCtD
Bromocriptine—Constipation—Sorafenib—liver cancer	0.000974	0.00538	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Epirubicin—liver cancer	0.000944	0.00522	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Sorafenib—liver cancer	0.000931	0.00515	CcSEcCtD
Bromocriptine—Diabetes mellitus—Doxorubicin—liver cancer	0.000911	0.00504	CcSEcCtD
Bromocriptine—Urticaria—Sorafenib—liver cancer	0.000905	0.005	CcSEcCtD
Bromocriptine—Body temperature increased—Sorafenib—liver cancer	0.0009	0.00498	CcSEcCtD
Bromocriptine—Abdominal pain—Sorafenib—liver cancer	0.0009	0.00498	CcSEcCtD
Bromocriptine—Hypoglycaemia—Epirubicin—liver cancer	0.000878	0.00485	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Epirubicin—liver cancer	0.000874	0.00483	CcSEcCtD
Bromocriptine—Lethargy—Epirubicin—liver cancer	0.000874	0.00483	CcSEcCtD
Bromocriptine—Cardiac failure congestive—Doxorubicin—liver cancer	0.000874	0.00483	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000857	0.00473	CcSEcCtD
Bromocriptine—Diplopia—Epirubicin—liver cancer	0.000857	0.00473	CcSEcCtD
Bromocriptine—Asthenia—Sorafenib—liver cancer	0.000817	0.00452	CcSEcCtD
Bromocriptine—Hypoglycaemia—Doxorubicin—liver cancer	0.000812	0.00449	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Doxorubicin—liver cancer	0.000809	0.00447	CcSEcCtD
Bromocriptine—Lethargy—Doxorubicin—liver cancer	0.000809	0.00447	CcSEcCtD
Bromocriptine—Ataxia—Epirubicin—liver cancer	0.000805	0.00445	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000793	0.00438	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—liver cancer	0.000793	0.00438	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Epirubicin—liver cancer	0.000782	0.00432	CcSEcCtD
Bromocriptine—Abdominal pain upper—Epirubicin—liver cancer	0.000782	0.00432	CcSEcCtD
Bromocriptine—Diarrhoea—Sorafenib—liver cancer	0.000779	0.00431	CcSEcCtD
Bromocriptine—Nasopharyngitis—Epirubicin—liver cancer	0.000766	0.00423	CcSEcCtD
Bromocriptine—Dizziness—Sorafenib—liver cancer	0.000753	0.00416	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—liver cancer	0.000745	0.00412	CcSEcCtD
Bromocriptine—Influenza—Epirubicin—liver cancer	0.00074	0.00409	CcSEcCtD
Bromocriptine—Dysphagia—Epirubicin—liver cancer	0.00074	0.00409	CcSEcCtD
Bromocriptine—Vomiting—Sorafenib—liver cancer	0.000724	0.004	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—liver cancer	0.000724	0.004	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000724	0.004	CcSEcCtD
Bromocriptine—Rash—Sorafenib—liver cancer	0.000718	0.00397	CcSEcCtD
Bromocriptine—Dermatitis—Sorafenib—liver cancer	0.000718	0.00397	CcSEcCtD
Bromocriptine—Headache—Sorafenib—liver cancer	0.000714	0.00394	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—liver cancer	0.000709	0.00392	CcSEcCtD
Bromocriptine—Dysphagia—Doxorubicin—liver cancer	0.000685	0.00379	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—liver cancer	0.000685	0.00379	CcSEcCtD
Bromocriptine—Pollakiuria—Epirubicin—liver cancer	0.000684	0.00378	CcSEcCtD
Bromocriptine—Nausea—Sorafenib—liver cancer	0.000677	0.00374	CcSEcCtD
Bromocriptine—Drowsiness—Epirubicin—liver cancer	0.00066	0.00365	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—liver cancer	0.000633	0.0035	CcSEcCtD
Bromocriptine—Sinusitis—Epirubicin—liver cancer	0.000619	0.00342	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—liver cancer	0.000611	0.00338	CcSEcCtD
Bromocriptine—Bradycardia—Epirubicin—liver cancer	0.000603	0.00333	CcSEcCtD
Bromocriptine—Rhinitis—Epirubicin—liver cancer	0.000594	0.00328	CcSEcCtD
Bromocriptine—Hypoaesthesia—Epirubicin—liver cancer	0.00059	0.00326	CcSEcCtD
Bromocriptine—Oedema peripheral—Epirubicin—liver cancer	0.000584	0.00323	CcSEcCtD
Bromocriptine—Connective tissue disorder—Epirubicin—liver cancer	0.000582	0.00322	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—liver cancer	0.000573	0.00317	CcSEcCtD
Bromocriptine—Visual impairment—Epirubicin—liver cancer	0.000571	0.00316	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—liver cancer	0.000558	0.00308	CcSEcCtD
Bromocriptine—Eye disorder—Epirubicin—liver cancer	0.000554	0.00306	CcSEcCtD
Bromocriptine—Tinnitus—Epirubicin—liver cancer	0.000552	0.00305	CcSEcCtD
Bromocriptine—Cardiac disorder—Epirubicin—liver cancer	0.00055	0.00304	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—liver cancer	0.00055	0.00304	CcSEcCtD
Bromocriptine—Hypoaesthesia—Doxorubicin—liver cancer	0.000546	0.00302	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—liver cancer	0.00054	0.00299	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—liver cancer	0.000539	0.00298	CcSEcCtD
Bromocriptine—Angiopathy—Epirubicin—liver cancer	0.000538	0.00297	CcSEcCtD
Bromocriptine—Mediastinal disorder—Epirubicin—liver cancer	0.000534	0.00295	CcSEcCtD
Bromocriptine—Arrhythmia—Epirubicin—liver cancer	0.000529	0.00293	CcSEcCtD
Bromocriptine—Visual impairment—Doxorubicin—liver cancer	0.000528	0.00292	CcSEcCtD
Bromocriptine—Alopecia—Epirubicin—liver cancer	0.000524	0.00289	CcSEcCtD
Bromocriptine—Mental disorder—Epirubicin—liver cancer	0.000519	0.00287	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—liver cancer	0.000512	0.00283	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—liver cancer	0.000511	0.00283	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—liver cancer	0.000509	0.00281	CcSEcCtD
Bromocriptine—Tension—Epirubicin—liver cancer	0.000506	0.0028	CcSEcCtD
Bromocriptine—Dysgeusia—Epirubicin—liver cancer	0.000505	0.00279	CcSEcCtD
Bromocriptine—Nervousness—Epirubicin—liver cancer	0.000501	0.00277	CcSEcCtD
Bromocriptine—Angiopathy—Doxorubicin—liver cancer	0.000497	0.00275	CcSEcCtD
Bromocriptine—Muscle spasms—Epirubicin—liver cancer	0.000496	0.00274	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—liver cancer	0.000494	0.00273	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—liver cancer	0.00049	0.00271	CcSEcCtD
Bromocriptine—Vision blurred—Epirubicin—liver cancer	0.000486	0.00269	CcSEcCtD
Bromocriptine—Alopecia—Doxorubicin—liver cancer	0.000484	0.00268	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—liver cancer	0.00048	0.00265	CcSEcCtD
Bromocriptine—Agitation—Epirubicin—liver cancer	0.000474	0.00262	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—liver cancer	0.000468	0.00259	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—liver cancer	0.000467	0.00258	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—liver cancer	0.000464	0.00256	CcSEcCtD
Bromocriptine—Vertigo—Epirubicin—liver cancer	0.000463	0.00256	CcSEcCtD
Bromocriptine—Syncope—Epirubicin—liver cancer	0.000463	0.00256	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—liver cancer	0.000459	0.00254	CcSEcCtD
Bromocriptine—Loss of consciousness—Epirubicin—liver cancer	0.000453	0.00251	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—liver cancer	0.00045	0.00249	CcSEcCtD
Bromocriptine—Convulsion—Epirubicin—liver cancer	0.000447	0.00247	CcSEcCtD
Bromocriptine—Hypertension—Epirubicin—liver cancer	0.000445	0.00246	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—liver cancer	0.000439	0.00242	CcSEcCtD
Bromocriptine—Anxiety—Epirubicin—liver cancer	0.000438	0.00242	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000436	0.00241	CcSEcCtD
Bromocriptine—Dry mouth—Epirubicin—liver cancer	0.000429	0.00237	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—liver cancer	0.000429	0.00237	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—liver cancer	0.000428	0.00237	CcSEcCtD
Bromocriptine—Confusional state—Epirubicin—liver cancer	0.000424	0.00235	CcSEcCtD
Bromocriptine—Oedema—Epirubicin—liver cancer	0.000421	0.00233	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—liver cancer	0.000419	0.00232	CcSEcCtD
Bromocriptine—Infection—Epirubicin—liver cancer	0.000418	0.00231	CcSEcCtD
Bromocriptine—Shock—Epirubicin—liver cancer	0.000414	0.00229	CcSEcCtD
Bromocriptine—Convulsion—Doxorubicin—liver cancer	0.000414	0.00229	CcSEcCtD
Bromocriptine—Nervous system disorder—Epirubicin—liver cancer	0.000413	0.00228	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—liver cancer	0.000412	0.00228	CcSEcCtD
Bromocriptine—Tachycardia—Epirubicin—liver cancer	0.000411	0.00227	CcSEcCtD
Bromocriptine—Skin disorder—Epirubicin—liver cancer	0.000409	0.00226	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—liver cancer	0.000405	0.00224	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000404	0.00223	CcSEcCtD
Bromocriptine—Anorexia—Epirubicin—liver cancer	0.000401	0.00222	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—liver cancer	0.000397	0.0022	CcSEcCtD
Bromocriptine—Hypotension—Epirubicin—liver cancer	0.000393	0.00217	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—liver cancer	0.000393	0.00217	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—liver cancer	0.00039	0.00215	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—liver cancer	0.000387	0.00214	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—liver cancer	0.000383	0.00212	CcSEcCtD
Bromocriptine—Nervous system disorder—Doxorubicin—liver cancer	0.000382	0.00211	CcSEcCtD
Bromocriptine—Insomnia—Epirubicin—liver cancer	0.000381	0.0021	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—liver cancer	0.00038	0.0021	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—liver cancer	0.000378	0.00209	CcSEcCtD
Bromocriptine—Paraesthesia—Epirubicin—liver cancer	0.000378	0.00209	CcSEcCtD
Bromocriptine—Dyspnoea—Epirubicin—liver cancer	0.000375	0.00207	CcSEcCtD
Bromocriptine—Somnolence—Epirubicin—liver cancer	0.000374	0.00207	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—liver cancer	0.000371	0.00205	CcSEcCtD
Bromocriptine—Dyspepsia—Epirubicin—liver cancer	0.000371	0.00205	CcSEcCtD
Bromocriptine—Decreased appetite—Epirubicin—liver cancer	0.000366	0.00202	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—liver cancer	0.000364	0.00201	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000363	0.00201	CcSEcCtD
Bromocriptine—Fatigue—Epirubicin—liver cancer	0.000363	0.00201	CcSEcCtD
Bromocriptine—Constipation—Epirubicin—liver cancer	0.00036	0.00199	CcSEcCtD
Bromocriptine—Insomnia—Doxorubicin—liver cancer	0.000352	0.00195	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—liver cancer	0.00035	0.00193	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—liver cancer	0.000347	0.00192	CcSEcCtD
Bromocriptine—Feeling abnormal—Epirubicin—liver cancer	0.000347	0.00192	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—liver cancer	0.000346	0.00191	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Epirubicin—liver cancer	0.000344	0.0019	CcSEcCtD
Bromocriptine—Dyspepsia—Doxorubicin—liver cancer	0.000343	0.0019	CcSEcCtD
Bromocriptine—Decreased appetite—Doxorubicin—liver cancer	0.000339	0.00187	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000336	0.00186	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—liver cancer	0.000336	0.00186	CcSEcCtD
Bromocriptine—Urticaria—Epirubicin—liver cancer	0.000334	0.00185	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—liver cancer	0.000333	0.00184	CcSEcCtD
Bromocriptine—Abdominal pain—Epirubicin—liver cancer	0.000333	0.00184	CcSEcCtD
Bromocriptine—Body temperature increased—Epirubicin—liver cancer	0.000333	0.00184	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—liver cancer	0.000321	0.00177	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000319	0.00176	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—liver cancer	0.000309	0.00171	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—liver cancer	0.000308	0.0017	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—liver cancer	0.000308	0.0017	CcSEcCtD
Bromocriptine—Asthenia—Epirubicin—liver cancer	0.000302	0.00167	CcSEcCtD
Bromocriptine—Diarrhoea—Epirubicin—liver cancer	0.000288	0.00159	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—liver cancer	0.000279	0.00154	CcSEcCtD
Bromocriptine—Dizziness—Epirubicin—liver cancer	0.000278	0.00154	CcSEcCtD
Bromocriptine—Vomiting—Epirubicin—liver cancer	0.000268	0.00148	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—liver cancer	0.000267	0.00147	CcSEcCtD
Bromocriptine—Rash—Epirubicin—liver cancer	0.000265	0.00147	CcSEcCtD
Bromocriptine—Dermatitis—Epirubicin—liver cancer	0.000265	0.00147	CcSEcCtD
Bromocriptine—Headache—Epirubicin—liver cancer	0.000264	0.00146	CcSEcCtD
Bromocriptine—Dizziness—Doxorubicin—liver cancer	0.000258	0.00142	CcSEcCtD
Bromocriptine—Nausea—Epirubicin—liver cancer	0.00025	0.00138	CcSEcCtD
Bromocriptine—Vomiting—Doxorubicin—liver cancer	0.000248	0.00137	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—liver cancer	0.000246	0.00136	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—liver cancer	0.000245	0.00136	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—liver cancer	0.000244	0.00135	CcSEcCtD
Bromocriptine—Nausea—Doxorubicin—liver cancer	0.000231	0.00128	CcSEcCtD
Bromocriptine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	1.08e-05	6.3e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MYC—liver cancer	1.08e-05	6.28e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TGFB1—liver cancer	1.07e-05	6.27e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MMP9—liver cancer	1.07e-05	6.23e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—HRAS—liver cancer	1.06e-05	6.2e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CDKN1A—liver cancer	1.06e-05	6.2e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MYC—liver cancer	1.06e-05	6.2e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1B—liver cancer	1.06e-05	6.2e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MYC—liver cancer	1.06e-05	6.2e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—PIK3CA—liver cancer	1.06e-05	6.19e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—PIK3CA—liver cancer	1.06e-05	6.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TGFB1—liver cancer	1.06e-05	6.18e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TGFB1—liver cancer	1.06e-05	6.18e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PPARG—liver cancer	1.05e-05	6.16e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—KRAS—liver cancer	1.05e-05	6.15e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	1.05e-05	6.15e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—PIK3CA—liver cancer	1.05e-05	6.15e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—VEGFA—liver cancer	1.05e-05	6.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	1.05e-05	6.13e-05	CbGpPWpGaD
Bromocriptine—DRD2—GPCR downstream signaling—AKT1—liver cancer	1.05e-05	6.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	1.04e-05	6.1e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1B—liver cancer	1.04e-05	6.1e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—liver cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—HRAS—liver cancer	1.04e-05	6.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—liver cancer	1.04e-05	6.07e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL2—liver cancer	1.04e-05	6.06e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—liver cancer	1.04e-05	6.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MAPK8—liver cancer	1.04e-05	6.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—RAF1—liver cancer	1.04e-05	6.05e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—AKT1—liver cancer	1.03e-05	6.04e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—IL6—liver cancer	1.03e-05	6.03e-05	CbGpPWpGaD
Bromocriptine—HTR2A—GPCR downstream signaling—AKT1—liver cancer	1.03e-05	6.03e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—liver cancer	1.03e-05	6.02e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—PIK3CA—liver cancer	1.03e-05	6.02e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—liver cancer	1.03e-05	5.99e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—liver cancer	1.02e-05	5.99e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—liver cancer	1.02e-05	5.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1B—liver cancer	1.02e-05	5.97e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL2—liver cancer	1.02e-05	5.97e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARA—liver cancer	1.02e-05	5.95e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—liver cancer	1.02e-05	5.95e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—IL6—liver cancer	1.02e-05	5.94e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—PIK3CA—liver cancer	1.01e-05	5.92e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CCND1—liver cancer	1.01e-05	5.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MTOR—liver cancer	1.01e-05	5.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	1.01e-05	5.91e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—GPCR downstream signaling—AKT1—liver cancer	1.01e-05	5.91e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—JUN—liver cancer	1.01e-05	5.9e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—VEGFA—liver cancer	1e-05	5.87e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—liver cancer	1e-05	5.85e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—liver cancer	1e-05	5.85e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL2—liver cancer	1e-05	5.84e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—VEGFA—liver cancer	1e-05	5.84e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—liver cancer	9.97e-06	5.82e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CCND1—liver cancer	9.96e-06	5.82e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—IL6—liver cancer	9.95e-06	5.81e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—liver cancer	9.95e-06	5.81e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—JUN—liver cancer	9.94e-06	5.8e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—KRAS—liver cancer	9.93e-06	5.8e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—liver cancer	9.9e-06	5.78e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—liver cancer	9.86e-06	5.76e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTP1—liver cancer	9.86e-06	5.76e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MMP9—liver cancer	9.82e-06	5.74e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HRAS—liver cancer	9.81e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—liver cancer	9.81e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—KRAS—liver cancer	9.8e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—KRAS—liver cancer	9.8e-06	5.73e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HRAS—liver cancer	9.8e-06	5.72e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CDKN1A—liver cancer	9.79e-06	5.72e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CCND1—liver cancer	9.75e-06	5.7e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HRAS—liver cancer	9.73e-06	5.69e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—JUN—liver cancer	9.73e-06	5.68e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—HMOX1—liver cancer	9.72e-06	5.68e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	9.72e-06	5.68e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—PIK3CA—liver cancer	9.68e-06	5.65e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MMP9—liver cancer	9.67e-06	5.65e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MYC—liver cancer	9.67e-06	5.65e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	9.66e-06	5.64e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—liver cancer	9.65e-06	5.64e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TGFB1—liver cancer	9.64e-06	5.63e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CDKN1A—liver cancer	9.63e-06	5.63e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—liver cancer	9.63e-06	5.62e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CD—liver cancer	9.6e-06	5.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MYC—liver cancer	9.58e-06	5.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—VEGFA—liver cancer	9.57e-06	5.59e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MAPK8—liver cancer	9.55e-06	5.58e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	9.55e-06	5.58e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HRAS—liver cancer	9.53e-06	5.57e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—AKT1—liver cancer	9.53e-06	5.57e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	9.5e-06	5.55e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—ALB—liver cancer	9.48e-06	5.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—liver cancer	9.47e-06	5.54e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MMP9—liver cancer	9.47e-06	5.53e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CDKN1A—liver cancer	9.43e-06	5.51e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MAPK8—liver cancer	9.4e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	9.39e-06	5.49e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—IL6—liver cancer	9.39e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HRAS—liver cancer	9.38e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—IL6—liver cancer	9.38e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—AKT1—liver cancer	9.38e-06	5.48e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—liver cancer	9.36e-06	5.47e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—IL6—liver cancer	9.32e-06	5.44e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—liver cancer	9.31e-06	5.44e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL2—liver cancer	9.29e-06	5.43e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—IL6—liver cancer	9.25e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MYC—liver cancer	9.24e-06	5.4e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TGFB1—liver cancer	9.22e-06	5.39e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MAPK8—liver cancer	9.21e-06	5.38e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MYC—liver cancer	9.2e-06	5.37e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—AKT1—liver cancer	9.18e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TGFB1—liver cancer	9.17e-06	5.36e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.14e-06	5.34e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—PIK3CA—liver cancer	9.13e-06	5.33e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—IL6—liver cancer	9.12e-06	5.33e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—PIK3CA—liver cancer	9.08e-06	5.31e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—GSTM1—liver cancer	9.06e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CCND1—liver cancer	9.06e-06	5.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—JUN—liver cancer	9.04e-06	5.28e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—PIK3CA—liver cancer	9e-06	5.26e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—PIK3CA—liver cancer	9e-06	5.26e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—IL6—liver cancer	8.98e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	8.97e-06	5.24e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HRAS—liver cancer	8.95e-06	5.23e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MYC—liver cancer	8.95e-06	5.23e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—KRAS—liver cancer	8.93e-06	5.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	8.92e-06	5.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—KRAS—liver cancer	8.85e-06	5.17e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—liver cancer	8.83e-06	5.16e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—VEGFA—liver cancer	8.82e-06	5.15e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MYC—liver cancer	8.8e-06	5.14e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MMP9—liver cancer	8.79e-06	5.14e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TGFB1—liver cancer	8.78e-06	5.13e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	8.76e-06	5.12e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—liver cancer	8.74e-06	5.1e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CG—liver cancer	8.72e-06	5.09e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—liver cancer	8.71e-06	5.09e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—liver cancer	8.71e-06	5.09e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—VEGFA—liver cancer	8.68e-06	5.07e-05	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—AKT1—liver cancer	8.66e-06	5.06e-05	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—AKT1—liver cancer	8.65e-06	5.05e-05	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—AKT1—liver cancer	8.6e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—liver cancer	8.6e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CYP1A1—liver cancer	8.59e-06	5.02e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—IL6—liver cancer	8.57e-06	5.01e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	8.55e-06	5e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—KRAS—liver cancer	8.54e-06	4.99e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	8.53e-06	4.98e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—VEGFA—liver cancer	8.5e-06	4.97e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—KRAS—liver cancer	8.5e-06	4.96e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HRAS—liver cancer	8.44e-06	4.93e-05	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—AKT1—liver cancer	8.42e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—liver cancer	8.42e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PPARG—liver cancer	8.41e-06	4.92e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CB—liver cancer	8.37e-06	4.89e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HRAS—liver cancer	8.33e-06	4.87e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HRAS—liver cancer	8.33e-06	4.87e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—AKT1—liver cancer	8.28e-06	4.84e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—KRAS—liver cancer	8.27e-06	4.83e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—PIK3CA—liver cancer	8.2e-06	4.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—KRAS—liver cancer	8.14e-06	4.75e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	8.13e-06	4.75e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MYC—liver cancer	8.12e-06	4.74e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TGFB1—liver cancer	8.1e-06	4.73e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—IL6—liver cancer	8.08e-06	4.72e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—liver cancer	8.01e-06	4.68e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MYC—liver cancer	7.99e-06	4.67e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—IL6—liver cancer	7.97e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—IL6—liver cancer	7.97e-06	4.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TGFB1—liver cancer	7.97e-06	4.65e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—liver cancer	7.94e-06	4.64e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—AKT1—liver cancer	7.91e-06	4.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	7.9e-06	4.61e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—liver cancer	7.86e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARA—liver cancer	7.86e-06	4.59e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—PIK3CA—liver cancer	7.85e-06	4.58e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MYC—liver cancer	7.82e-06	4.57e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—liver cancer	7.82e-06	4.57e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—PIK3CA—liver cancer	7.81e-06	4.56e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TGFB1—liver cancer	7.8e-06	4.56e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CD—liver cancer	7.66e-06	4.48e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	7.59e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—liver cancer	7.59e-06	4.44e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HRAS—liver cancer	7.59e-06	4.43e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—ALB—liver cancer	7.57e-06	4.42e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—liver cancer	7.55e-06	4.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HRAS—liver cancer	7.52e-06	4.39e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—KRAS—liver cancer	7.5e-06	4.38e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—PIK3CA—liver cancer	7.47e-06	4.37e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—AKT1—liver cancer	7.46e-06	4.36e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—AKT1—liver cancer	7.42e-06	4.33e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—KRAS—liver cancer	7.38e-06	4.31e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—PIK3CA—liver cancer	7.38e-06	4.31e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—AKT1—liver cancer	7.36e-06	4.3e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—AKT1—liver cancer	7.36e-06	4.3e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—liver cancer	7.35e-06	4.29e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MYC—liver cancer	7.27e-06	4.24e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—IL6—liver cancer	7.27e-06	4.24e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HRAS—liver cancer	7.26e-06	4.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	7.25e-06	4.23e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—liver cancer	7.23e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—KRAS—liver cancer	7.23e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HRAS—liver cancer	7.22e-06	4.22e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—IL6—liver cancer	7.2e-06	4.21e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HRAS—liver cancer	7.03e-06	4.1e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—IL6—liver cancer	6.95e-06	4.06e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HRAS—liver cancer	6.91e-06	4.04e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—IL6—liver cancer	6.91e-06	4.04e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—PIK3CA—liver cancer	6.89e-06	4.03e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—PIK3CA—liver cancer	6.78e-06	3.96e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CG—liver cancer	6.73e-06	3.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—IL6—liver cancer	6.72e-06	3.93e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—KRAS—liver cancer	6.71e-06	3.92e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—AKT1—liver cancer	6.7e-06	3.92e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CB—liver cancer	6.68e-06	3.9e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—liver cancer	6.67e-06	3.89e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—AKT1—liver cancer	6.64e-06	3.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—PIK3CA—liver cancer	6.64e-06	3.88e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—IL6—liver cancer	6.62e-06	3.87e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—liver cancer	6.56e-06	3.83e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PPARG—liver cancer	6.49e-06	3.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—liver cancer	6.42e-06	3.75e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—AKT1—liver cancer	6.41e-06	3.75e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—AKT1—liver cancer	6.38e-06	3.73e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HRAS—liver cancer	6.38e-06	3.72e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HRAS—liver cancer	6.27e-06	3.66e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—AKT1—liver cancer	6.2e-06	3.62e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	6.17e-06	3.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HRAS—liver cancer	6.14e-06	3.59e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—AKT1—liver cancer	6.11e-06	3.57e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—IL6—liver cancer	6.1e-06	3.56e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—AKT1—liver cancer	6.03e-06	3.52e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—IL6—liver cancer	6e-06	3.51e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—liver cancer	5.97e-06	3.49e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CD—liver cancer	5.91e-06	3.46e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—IL6—liver cancer	5.88e-06	3.43e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—ALB—liver cancer	5.84e-06	3.41e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HRAS—liver cancer	5.71e-06	3.33e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—AKT1—liver cancer	5.63e-06	3.29e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—AKT1—liver cancer	5.54e-06	3.24e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—IL6—liver cancer	5.46e-06	3.19e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—AKT1—liver cancer	5.42e-06	3.17e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CB—liver cancer	5.16e-06	3.01e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—PIK3CA—liver cancer	5.1e-06	2.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—AKT1—liver cancer	5.04e-06	2.94e-05	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—AKT1—liver cancer	4.17e-06	2.43e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—PIK3CA—liver cancer	4.07e-06	2.38e-05	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—AKT1—liver cancer	3.33e-06	1.94e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—PIK3CA—liver cancer	3.14e-06	1.84e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—AKT1—liver cancer	2.57e-06	1.5e-05	CbGpPWpGaD
